Elm Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,373
| Closed | -$273K | – | 50 |
|
|
2021
Q4 | $273K | Hold |
4,373
| – | – | 0.15% | 74 |
|
|
2021
Q3 | $259K | Sell |
4,373
-200
| -4% | -$13.2K | 0.16% | 76 |
|
|
2021
Q2 | $306K | Hold |
4,573
| – | – | 0.18% | 70 |
|
|
2021
Q1 | $289K | Hold |
4,573
| – | – | 0.18% | 70 |
|
|
2020
Q4 | $284K | Sell |
4,573
-2,035
| -31% | -$125K | 0.17% | 69 |
|
|
2020
Q3 | $398K | Sell |
6,608
-1,350
| -17% | -$81.3K | 0.27% | 56 |
|
|
2020
Q2 | $468K | Hold |
7,958
| – | – | 0.33% | 52 |
|
|
2020
Q1 | $444K | Hold |
7,958
| – | – | 0.36% | 49 |
|
|
2019
Q4 | $511K | Buy |
7,958
+600
| +8% | +$34.4K | 0.32% | 55 |
|
|
2019
Q3 | $373K | Hold |
7,358
| – | – | 0.25% | 60 |
|
|
2019
Q2 | $334K | Buy |
7,358
+400
| +6% | +$18.6K | 0.23% | 64 |
|
|
2019
Q1 | $332K | Buy |
6,958
+570
| +9% | +$28.4K | 0.23% | 63 |
|
|
2018
Q4 | $332K | Sell |
6,388
-375
| -6% | -$20.1K | 0.27% | 58 |
|
|
2018
Q3 | $420K | Buy |
6,763
+375
| +6% | +$22.3K | 0.28% | 54 |
|
|
2018
Q2 | $354K | Hold |
6,388
| – | – | 0.27% | 57 |
|
|
2018
Q1 | $404K | Sell |
6,388
-195
| -3% | -$12.5K | 0.31% | 52 |
|
|
2017
Q4 | $403K | Sell |
6,583
-325
| -5% | -$20.3K | 0.3% | 52 |
|
|
2017
Q3 | $440K | Sell |
6,908
-208
| -3% | -$12.1K | 0.35% | 48 |
|
|
2017
Q2 | $397K | Hold |
7,116
| – | – | 0.33% | 50 |
|
|
2017
Q1 | $387K | Hold |
7,116
| – | – | 0.32% | 49 |
|
|
2016
Q4 | $416K | Hold |
7,116
| – | – | 0.37% | 46 |
|
|
2016
Q3 | $384K | Hold |
7,116
| – | – | 0.36% | 49 |
|
|
2016
Q2 | $523K | Hold |
7,116
| – | – | 0.5% | 40 |
|
|
2016
Q1 | $455K | Hold |
7,116
| – | – | 0.44% | 42 |
|
|
2015
Q4 | $490K | Sell |
7,116
-150
| -2% | -$9.91K | 0.48% | 39 |
|
|
2015
Q3 | $430K | Hold |
7,266
| – | – | 0.45% | 40 |
|
|
2015
Q2 | $483K | Buy |
7,266
+204
| +3% | +$13.4K | 0.45% | 38 |
|
|
2015
Q1 | $455K | Sell |
7,062
-100
| -1% | -$6.26K | 0.42% | 45 |
|
|
2014
Q4 | $423K | Hold |
7,162
| – | – | 0.39% | 47 |
|
|
2014
Q3 | $367K | Hold |
7,162
| – | – | 0.35% | 49 |
|
|
2014
Q2 | $347K | Sell |
7,162
-200
| -3% | -$9.86K | 0.32% | 52 |
|
|
2014
Q1 | $382K | Sell |
7,362
-225
| -3% | -$12K | 0.37% | 47 |
|
|
2013
Q4 | $403K | Buy |
+7,587
| New | +$386K | 0.39% | 47 |
|
Other funds holding BMY
Elm Advisors's BMY Position: Q1 2022 in Review
Elm Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2022, closing a stake of 4,373 shares — an estimated $273K sold.
Elm Advisors first reported a position in BMY in Q4 2013 and held it in 33 quarters. The position peaked at $523K in Q2 2016. 2,515 funds tracked by Wall St. Rank hold BMY as of Q1 2022.
- Elm Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2022 after selling out during the quarter.
- Elm Advisors sold 4,373 Bristol-Myers Squibb shares in Q1 2022, an estimated $273K.
- Elm Advisors first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 33 quarters.
- Elm Advisors's Bristol-Myers Squibb position peaked at $523K in Q2 2016.
- 2,515 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2022.
Based on Elm Advisors's 13F filing for Q1 2022, filed 1 Apr 2022.